ADMA Biologics Inc (ADMA)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	219,553	187,306	152,300	111,537	88,942	72,033	57,037	48,116	35,265	24,599	15,327	6,556	1,172	-7,494	-9,458	-14,164	-19,071	-13,571	-12,686	-10,908
Revenue (ttm)	US$ in thousands	426,454	382,809	330,245	283,177	258,216	234,293	208,108	181,890	154,079	130,481	110,072	93,998	80,944	68,517	58,112	48,069	42,220	40,301	37,248	36,021
Gross profit margin		51.48%	48.93%	46.12%	39.39%	34.44%	30.74%	27.41%	26.45%	22.89%	18.85%	13.92%	6.97%	1.45%	-10.94%	-16.28%	-29.47%	-45.17%	-33.67%	-34.06%	-30.28%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $219,553K ÷ $426,454K
= 51.48%

The gross profit margin of ADMA Biologics Inc has shown a positive trend over the analyzed periods from March 31, 2020, to December 31, 2024, indicating improved efficiency in generating profits from sales after deducting the cost of goods sold. The margin started at a negative value in 2020, indicating that the cost of goods sold was higher than the revenue generated, leading to a loss on each sale. However, there was a gradual improvement in the gross profit margin over time.

From March 31, 2022, onwards, the company consistently exhibited positive gross profit margins, reflecting its ability to increase revenue while effectively managing its production costs. The margin saw significant growth in the later periods, reaching over 50% by December 31, 2024. This suggests that ADMA Biologics Inc has been successful in optimizing its production processes, controlling costs, and possibly even improving pricing strategies, leading to healthier profit margins.

The positive trend in the gross profit margin indicates that ADMA Biologics Inc has been on a path towards sustainable profitability, which is a positive signal for investors and stakeholders. It showcases the company's ability to efficiently convert its sales into profits, which is essential for long-term financial stability and growth.